CSIMarket
 
China Pharma Holdings Inc   (CPHI)
Other Ticker:  
 
 
Price: $0.3720 $0.01 3.535%
Day's High: $0.372 Week Perf: 10.85 %
Day's Low: $ 0.35 30 Day Perf: 294.9 %
Volume (M): 66 52 Wk High: $ 0.54
Volume (M$): $ 24 52 Wk Avg: $0.22
Open: $0.36 52 Wk Low: $0.07



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 13
 Employees -
 Revenues (TTM) (Millions $) 8
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

China Pharma Holdings Inc
China Pharma Holdings Inc is a specialty pharmaceutical company based in China. It engages in the research, development, manufacture, and sale of generic and branded drugs primarily in China. The company focuses on areas such as cardiovascular, central nervous system, infectious, and digestive diseases, among others. It supplies its products to hospitals, clinics, and retail pharmacies. China Pharma Holdings Inc also exports its products to international markets. The company strives to meet the increasing demand for high-quality and affordable pharmaceuticals in China and other countries.


   Company Address: Second Floor, No. 17, Jinpan Road Hainan Province 570216
   Company Phone Number: 898-6681-1730   Stock Exchange / Ticker: NYSE CPHI
   CPHI is expected to report next financial results on March 29, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



China Pharma Holdings Inc

Headline: China Pharma Holdings Inc Reports Significant Loss in Recent Fiscal Period Amidst Decreased Order Volume 2.

China Pharma Holdings Inc (CPHI) is a pharmaceutical company based in China. However, in the fiscal period closing September 30, 2023, the company experienced lower demand, leading to diminishing revenue and an increased shortfall. The deficits have widened to $-0.06 per share, while revenue decreased by -8.264% to $1.80 million year on year.
Comparatively, in the previous reporting period, the company achieved revenue of $1.10 million and a bottom line of $-0.06 per share. During the fiscal period closing September 30, 2023, China Pharma Holdings Inc reported a net shortfall of $-0.778 million, slightly lower than the $-0.791 million deficit in the corresponding reporting period a year ago.

China Pharma Holdings Inc

China Pharma Holdings Inc Reports Larger Shortfall in Most Recent Fiscal Period, Reflecting Weak Demand

Financial news report:
China Pharma Holdings Inc (NYSE: CPHI) faced increased losses in the second quarter of 2023 due to weak demand. The company's net loss per share rose to $-0.06 from $-0.02, reflecting the declining revenue. Revenue dropped by -31.943% to $1.10 million compared to $1.61 million in the same period the previous year. This is in contrast to the first quarter, where revenue tumbled by -43.995% to $1.96 million, and net loss per share stood at $-0.06.
However, there is a silver lining as the company's net deficit decreased to $-0.593 million in the most recent fiscal period, down from $-0.888 million in the previous year's reporting period. Despite the losses, China Pharma Holdings Inc's inventories and supplies saw an increase to $3.9 million, indicating potential future growth. The level of accounts receivable also rose to $0.4 million, which suggests rising demand.






 

China Pharma Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com